MAP2K2 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Products
MAP2K2 (untagged)-Human mitogen-activated protein kinase kinase 2 (MAP2K2)
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL5 |
MAP2K2 (untagged)-Kinase deficient mutant (K101M) of Human mitogen-activated protein kinase kinase 2 (MAP2K2)
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL4 |
MAP2K2 MS Standard C13 and N15-labeled recombinant protein (NP_109587)
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
3' UTR clone of mitogen-activated protein kinase kinase 2 (MAP2K2) for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Reporters
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Brands
QC Levels
Pathways
- Acute myeloid leukemia (60)
- B cell receptor signaling pathway (60)
- Bladder cancer (60)
- Chronic myeloid leukemia (60)
- Endometrial cancer (60)
- ErbB signaling pathway (60)
- Fc epsilon RI signaling pathway (60)
- Gap junction (60)
- Glioma (60)
- GnRH signaling pathway (60)
- Insulin signaling pathway (60)
- Long-term depression (60)
- Long-term potentiation (60)
- MAPK signaling pathway (60)
- Melanogenesis (60)
- Melanoma (60)
- Natural killer cell mediated cytotoxicity (60)
- Neurotrophin signaling pathway (60)
- Non-small cell lung cancer (60)
- Pathways in cancer (60)
- Prion diseases (60)
- Prostate cancer (60)
- Regulation of actin cytoskeleton (60)
- Renal cell carcinoma (60)
- T cell receptor signaling pathway (60)
- Thyroid cancer (60)
- Toll-like receptor signaling pathway (60)
- VEGF signaling pathway (60)
- Vascular smooth muscle contraction (60)
